Emcure Pharma net profit rises 48% YoY

New Delhi: Emcure Pharmaceuticals on Wednesday posted a 48 per cent year-on-year increase in its consolidated profit after tax at Rs 231 crore for the third quarter ended December 31, 2025, led by robust sales growth in business verticals. The drug firm reported a Profit After Tax (PAT) of Rs 156 crore for the October-December period of last fiscal.